Literature DB >> 32144233

Research Progress in Liver-Regenerating Microenvironment and DNA Methylation in Hepatocellular Carcinoma: The Role of Traditional Chinese Medicine.

Minggang Wang1, Qianling Ye2, Dewen Mao3, Hanmin Li1.   

Abstract

The development, progression, recurrence, and metastasis of hepatocellular carcinoma (HCC) are closely associated with an abnormal liver-regenerating microenvironment (LRM). Therefore, preventing and reversing an abnormal LRM is a potential therapeutic strategy against HCC. Studies are increasingly focusing on the impact of regeneration, fibrosis, angiogenesis, inflammation, immunomodulation, and hepatic stem cells on HCC development and progression. As a key epigenetic mechanism, DNA methylation is extensively involved in regulating physiological and pathological pathways. In this review, we summarize recent findings on the role of DNA methylation in the fibrotic, angiogenic, inflammatory/immune, and stem cell microenvironments of HCC, and discuss new advances in Traditional Chinese Medicine (TCM) on influencing the abnormal LRM, so as to gain new insights into alleviating the abnormal LRM via regulating DNA methylation by TCM.

Entities:  

Mesh:

Year:  2020        PMID: 32144233     DOI: 10.12659/MSM.920310

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  6 in total

1.  Data Mining and Systems Pharmacology to Elucidate Effectiveness and Mechanisms of Chinese Medicine in Treating Primary Liver Cancer.

Authors:  Zhen Zhang; Jun-Wei Li; Pu-Hua Zeng; Wen-Hui Gao; Xue-Fei Tian
Journal:  Chin J Integr Med       Date:  2021-08-25       Impact factor: 1.978

2.  Increased RBM12 expression predicts poor prognosis in hepatocellular carcinoma based on bioinformatics.

Authors:  Cheng Gao; Jianbo Shen; Weipeng Chen; Lanqing Yao; Xiaoliang Liang; Renfei Zhu; Zhong Chen
Journal:  J Gastrointest Oncol       Date:  2021-08

3.  Usefulness of Circulating Methylated p16 as a Noninvasive Molecular Biomarker for Hepatitis C-Related Hepatocellular Carcinoma with Normal Serum Alpha-Fetoprotein Levels.

Authors:  Wael Abd Elgwad Elsewify; Elham Ahmed Hassan; Mohamed A Mekky; Abeer Sharaf El-Din Abd El-Rehim; Zain El-Abdeen Ahmed Sayed; Mohamed Omar Abdel Malek; Tarek T H ElMelegy; Abeer Sabry
Journal:  Int J Gen Med       Date:  2020-04-30

4.  SPC25 overexpression promotes tumor proliferation and is prognostic of poor survival in hepatocellular carcinoma.

Authors:  Baozhu Zhang; Qing Zhou; Qiankun Xie; Xiaohui Lin; Wenqiang Miao; Zhaoguang Wei; Tingting Zheng; Zuoliang Pang; Haosheng Liu; Xi Chen
Journal:  Aging (Albany NY)       Date:  2020-12-19       Impact factor: 5.682

5.  Ophiopogonin‑B targets PTP1B to inhibit the malignant progression of hepatocellular carcinoma by regulating the PI3K/AKT and AMPK signaling pathways.

Authors:  Fang Yuan; Qian Gao; Hailin Tang; Jun Shi; Yiqun Zhou
Journal:  Mol Med Rep       Date:  2022-02-16       Impact factor: 2.952

6.  Determining the Traditional Chinese Medicine (TCM) Syndrome with the Best Prognosis of HBV-Related HCC and Exploring the Related Mechanism Using Network Pharmacology.

Authors:  Zhulin Wu; Chunshan Wei; Lianan Wang; Li He
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-29       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.